# Clinical Trial to Assess the Efficacy of Tranexamic Acid in Reducing Blood Loss in Hip Fracture Patients.

> **NCT05489185** · PHASE4 · UNKNOWN · sponsor: **Biogipuzkoa Health Research Institute** · enrollment: 644 (estimated)

## Conditions studied

- Hip Fractures

## Interventions

- **DRUG:** Tranexamic acid
- **OTHER:** Physiologic saline

## Key facts

- **NCT ID:** NCT05489185
- **Lead sponsor:** Biogipuzkoa Health Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-30
- **Primary completion:** 2024-06-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 644 (ESTIMATED)
- **Last updated:** 2023-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05489185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05489185, "Clinical Trial to Assess the Efficacy of Tranexamic Acid in Reducing Blood Loss in Hip Fracture Patients.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05489185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*